Literature DB >> 32399911

Responsibilities, Strategies, and Practice Factors in Clinical Cost Conversations: a US Physician Survey.

Rahma Warsame1,2, Lindsay Riordan3, Sarah Jenkins4, Kandace Lackore4, Joel Pacyna4,5, Ryan Antiel6, Timothy Beebe7, Mark Liebow5,8, Bjorg Thorsteinsdottir9,5,10, Michael Grover11, Matthew Wynia12,13, Susan Dorr Goold14,15, Matthew DeCamp12,13, Marion Danis16, Jon Tilburt9,4,5,8.   

Abstract

BACKGROUND: Physicians play a key role in mitigating and managing costs in healthcare which are rising.
OBJECTIVE: Conduct a cross-sectional survey in 2017, comparing results to a 2012 survey to understand US physicians' evolving attitudes and strategies concerning healthcare costs. PARTICIPANTS: Random sample of 1200 US physicians from the AMA Masterfile. MEASURES: Physician views on responsibility for costs of care, enthusiasm for cost-saving strategies, cost-consciousness scale, and practice strategies on addressing cost. KEY
RESULTS: Among 1200 physicians surveyed in 2017, 489 responded (41%). In 2017, slightly more physicians reported that physicians have a major responsibility for addressing healthcare costs (32% vs. 27%, p = 0.03). In 2017, more physicians attributed "major responsibility" for addressing healthcare costs to pharmaceutical companies (68% vs. 56%, p < 0.001) and hospital and health systems (63% vs. 56%%, p = 0.008) in contrast to 2012. Fewer respondents in 2017 attributed major responsibility for addressing costs to trial lawyers (53% vs. 59%, p = 0.007) and patients (42% vs. 52%, p < 0.0001) as compared to 2012. Physician enthusiasm for patient-focused cost-containment strategies like high deductible health plans and higher co-pays (62% vs. 42%, p < 0.0001 and 62% vs. 39%, p < 0.0001, not enthusiastic, respectively) declined. Physicians reported that when they discussed cost, it resulted in a change in disease management 56% of the time. Cost-consciousness within surveyed physicians had not changed meaningfully in 2017 since 2012 (31.7 vs. 31.2). Most physicians continued to agree that decision support tools showing costs would be helpful in their practice (> 70%). After adjusting for specialty, political affiliation, practice setting, age, and gender, only democratic/independent affiliation remained a significant predictor of cost-consciousness. CONCLUSIONS AND RELEVANCE: US physicians increasingly attribute responsibility for rising healthcare costs to organizations and express less enthusiasm for strategies that increase patient out-of-pocket cost. Interventions that focus on physician knowledge and communication strategies regarding cost of care may be helpful.

Entities:  

Mesh:

Year:  2020        PMID: 32399911      PMCID: PMC7351917          DOI: 10.1007/s11606-020-05807-0

Source DB:  PubMed          Journal:  J Gen Intern Med        ISSN: 0884-8734            Impact factor:   5.128


  26 in total

1.  High-cost generic drugs--implications for patients and policymakers.

Authors:  Jonathan D Alpern; William M Stauffer; Aaron S Kesselheim
Journal:  N Engl J Med       Date:  2014-11-13       Impact factor: 91.245

Review 2.  The effect of charge display on cost of care and physician practice behaviors: a systematic review.

Authors:  Celine Goetz; Stephen R Rotman; George Hartoularos; Tara F Bishop
Journal:  J Gen Intern Med       Date:  2015-02-18       Impact factor: 5.128

3.  Liking Health Reform But Turned Off By Toxic Politics.

Authors:  Lawrence R Jacobs; Suzanne Mettler
Journal:  Health Aff (Millwood)       Date:  2016-04-13       Impact factor: 6.301

Review 4.  Priorities among effective clinical preventive services: results of a systematic review and analysis.

Authors:  Michael V Maciosek; Ashley B Coffield; Nichol M Edwards; Thomas J Flottemesch; Michael J Goodman; Leif I Solberg
Journal:  Am J Prev Med       Date:  2006-07       Impact factor: 5.043

5.  Exploring public attitudes towards approaches to discussing costs in the clinical encounter.

Authors:  Marion Danis; Roseanna Sommers; Jean Logan; Beverly Weidmer; Shirley Chen; Susan Goold; Steven Pearson; Greer Donley; Elizabeth McGlynn
Journal:  J Gen Intern Med       Date:  2013-07-24       Impact factor: 5.128

6.  Conversations About Financial Issues in Routine Oncology Practices: A Multicenter Study.

Authors:  Rahma Warsame; Cassie C Kennedy; Ashok Kumbamu; Megan Branda; Cara Fernandez; Brittany Kimball; Aaron L Leppin; Thomas O'Byrne; Aminah Jatoi; Heinz-Josef Lenz; Jon C Tilburt
Journal:  J Oncol Pract       Date:  2019-06-04       Impact factor: 3.840

7.  Views of US physicians about controlling health care costs.

Authors:  Jon C Tilburt; Matthew K Wynia; Robert D Sheeler; Bjorg Thorsteinsdottir; Katherine M James; Jason S Egginton; Mark Liebow; Samia Hurst; Marion Danis; Susan Dorr Goold
Journal:  JAMA       Date:  2013-07-24       Impact factor: 56.272

8.  Physician Experience and Attitudes Toward Addressing the Cost of Cancer Care.

Authors:  Ivy Altomare; Blair Irwin; Syed Yousuf Zafar; Kevin Houck; Bailey Maloney; Rachel Greenup; Jeffrey Peppercorn
Journal:  J Oncol Pract       Date:  2016-02-16       Impact factor: 3.840

9.  Patient-oncologist cost communication, financial distress, and medication adherence.

Authors:  Christine M Bestvina; Leah L Zullig; Christel Rushing; Fumiko Chino; Gregory P Samsa; Ivy Altomare; James Tulsky; Peter Ubel; Deborah Schrag; Jon Nicolla; Amy P Abernethy; Jeffrey Peppercorn; S Yousuf Zafar
Journal:  J Oncol Pract       Date:  2014-05       Impact factor: 3.840

10.  The Affordable Care Act Insurance Reforms: Where Are We Now, and What's Next?

Authors:  M Claire Borelli; Miryam Bujanda; Krista Maier
Journal:  Clin Diabetes       Date:  2016-01
View more
  2 in total

1.  Capsule Commentary for Warsame et al., Responsibilities, Strategies and Practice Factors in Clinical Cost Conversations: a US Physician Survey.

Authors:  Ksenia Gorbenko; Himanshu Joshi; Serena Zhan
Journal:  J Gen Intern Med       Date:  2020-07       Impact factor: 5.128

2.  Cost-consciousness among Chinese medical staff: a cross-sectional survey.

Authors:  Fei Liang; Shu Hu; Youqi Guo
Journal:  BMC Health Serv Res       Date:  2022-06-06       Impact factor: 2.908

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.